Literature DB >> 28808841

Prognostic significance of myocardial energy expenditure and myocardial efficiency in patients with heart failure with reduced ejection fraction.

Mehmet S Cetin1, Elif H Ozcan Cetin2, Ugur Canpolat3, Hatice Sasmaz2, Ahmet Temizhan2, Sinan Aydogdu2.   

Abstract

In heart failure with reduced ejection fraction (HFrEF) patients, myocardial blood flow (MBF), myocardial energy expenditure (MEE), myocardial efficiency has been poorly evaluated because of the necessity of invasive procedures in the determination of these parameters. Transthoracic echocardiography (TTE) can provide reliable data for MEE, MBF (via coronary sinus (CS) flows). Also, myocardial efficiency can be evaluated by the MEE to MBF ratio. We aim to assess MBF, MEE and energy efficiency and the prognostic value of these parameters in HFrEF. In this prospective study, a total of 80 patients with HFrEF due to either ischemic or non-ischemic etiology and 20 healthy control subjects were included. Median follow-up duration was 901 (27-1004) days. MBF was calculated via coronary sinus blood flow. MEE was measured from circumferential end-systolic stress, stroke volume and left ventricular ejection time. MEE to MBF ratio was determined as MEf. Primary composite end-point (CEP) was cardiovascular mortality, heart transplantation or mechanical circulatory support. MEE and MEf were lower and MBF per minute was higher in HF group compared to control subjects whereas MBF per 100 g left ventricular mass was not different. MEE and MEf have significantly negative correlation with troponin I, BNP, uric acid and positive correlation with epicardial fat thickness. In Cox regression analysis, per one calorie decrease of MEE was associated 4.3 times increased risk [HR 4.396 (95% CI 1.230-15.716)] and per one percent decrease of MEf was associated 3.3 times increased risk of CEP [HR 3.343 (95% CI 1.025-10.905)]. Our study demonstrated that while MEE and MEf diminished in HFrEF, MBF preserved with the symptomatic progression of HF. MEE and MEf were found to be associated with important prognostic markers and independent predictors of CEP in HFrEF. Evaluation of MEE, MBF and MEf with echocardiography may provide an additional data regarding prognostic assessment of HFrEF population.

Entities:  

Keywords:  Heart failure; Myocardial blood flow; Myocardial efficiency; Myocardial energy expenditure

Mesh:

Year:  2017        PMID: 28808841     DOI: 10.1007/s10554-017-1226-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout.

Authors:  E Braunwald
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

2.  Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

Authors:  S J Sarnoff; E Braunwald; G H Welch; R B Case; W N Stainsby; R Macruz
Journal:  Am J Physiol       Date:  1958-01

Review 3.  Myocardial energetics and efficiency: current status of the noninvasive approach.

Authors:  Paul Knaapen; Tjeerd Germans; Juhani Knuuti; Walter J Paulus; Pieter A Dijkmans; Cornelis P Allaart; Adriaan A Lammertsma; Frans C Visser
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

4.  The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man.

Authors:  R J BING; M M HAMMOND
Journal:  Am Heart J       Date:  1949-07       Impact factor: 4.749

Review 5.  Echocardiographic epicardial fat: a review of research and clinical applications.

Authors:  Gianluca Iacobellis; Howard J Willens
Journal:  J Am Soc Echocardiogr       Date:  2009-12       Impact factor: 5.251

6.  Myocardial blood flow and lactate metabolism at rest and during exercise with reduced arterial oxygen content.

Authors:  J Grubbström; B Berglund; L Kaijser
Journal:  Acta Physiol Scand       Date:  1991-08

7.  Coronary slow flow phenomenon: Not only low in flow rate but also in myocardial energy expenditure.

Authors:  M S Cetin; E H Ozcan Cetin; D Aras; S Topaloglu; S Aydogdu
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-06-17       Impact factor: 4.222

Review 8.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

9.  Left ventricular stress and compliance in man. With special reference to normalized ventricular function curves.

Authors:  W H Gaasch; W E Battle; A A Oboler; J S Banas; H J Levine
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

Review 10.  Regulation of coronary blood flow during exercise.

Authors:  Dirk J Duncker; Robert J Bache
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

View more
  3 in total

1.  Circulatory efficiency in patients with severe aortic valve stenosis before and after aortic valve replacement.

Authors:  S Nordmeyer; C B Lee; L Goubergrits; C Knosalla; F Berger; V Falk; N Ghorbani; H Hireche-Chikaoui; M Zhu; S Kelle; T Kuehne; M Kelm
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-01       Impact factor: 5.364

2.  Impact of Myocardial Energy Expenditure and Diastolic Dysfunction on One Year Outcome Patients With HFpEF.

Authors:  Yu Wang; Yalan Cao; Shuting Xiang; Shunji Liang; Xiumei Yang; Ning Zhu; Weiyi Fang; Qin Yu
Journal:  Front Physiol       Date:  2022-04-04       Impact factor: 4.755

3.  Relationship between myocardial energy expenditure and postoperative ejection fraction in patients with severe mitral regurgitation.

Authors:  Hicaz Zencirkiran Agus; Gamze Babur Guler; Mehmet Ali Astarcioglu; Ahmet Guner; Ismail Gurbak; Oya Atamaner; Anil Sahin; Ahmet Yasar Cizgici; Alev Kilicgedik
Journal:  Anatol J Cardiol       Date:  2020-10       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.